7Baggers
 small cap stocks to research - november 10th  MarketBeat Sat, 15 Nov 2025 08:25:59 GMT
 galecto (glto) stock price, quote, news & history  Benzinga Sat, 15 Nov 2025 00:59:00 GMT
 Small Cap Stocks To Research - November 10th  MarketBeat Fri, 14 Nov 2025 08:00:00 GMT
 small cap stocks to research - november 10th  MarketBeat Thu, 13 Nov 2025 16:37:01 GMT
 US: Galecto acquires Damora Tx and raises US$285m from Series C  Investors in Healthcare Wed, 12 Nov 2025 08:54:13 GMT
 small cap stocks to research - november 10th  MarketBeat Tue, 11 Nov 2025 20:33:25 GMT
 A Week Is A Long Time In Biotech, Just Ask Galecto  Citeline News & Insights Tue, 11 Nov 2025 16:37:36 GMT
 galecto shows market leadership with jump to 99 rs rating  Investor's Business Daily Tue, 11 Nov 2025 08:00:00 GMT
 This Penny Stock Just Quadrupled. Should You Buy It Now?  Yahoo Finance Mon, 10 Nov 2025 21:05:04 GMT
 Biotech Mergers And Trial Successes Send Shares Higher  Finimize Mon, 10 Nov 2025 18:40:57 GMT
 Galecto shares skyrocket after biotech acquisition  Rolling Out Mon, 10 Nov 2025 14:37:08 GMT
 Galecto Completes Acquisition of Damora Therapeutics  TipRanks Mon, 10 Nov 2025 13:50:57 GMT
 Galecto (GLTO) Expands with Damora Therapeutics Acquisition  GuruFocus Mon, 10 Nov 2025 13:46:27 GMT
 galecto, inc. announces board and executive changes  TradingView Mon, 10 Nov 2025 13:25:00 GMT
 Galecto Acquires Damora Therapeutics  citybiz Mon, 10 Nov 2025 12:57:23 GMT
 Why Is Galecto Stock (GLTO) Up 285% Today?  TipRanks Mon, 10 Nov 2025 12:55:23 GMT
 Galecto stock soars after Damora Therapeutics acquisition  Investing.com Mon, 10 Nov 2025 12:23:04 GMT
 Galecto Announces Acquisition of Damora Therapeutics  The Manila Times Mon, 10 Nov 2025 12:22:00 GMT
 galecto (nasdaq:glto) stock rating upgraded by wall street zen  Defense World Mon, 10 Nov 2025 08:01:13 GMT
 Galecto, Inc. acquired Damora Therapeutics, Inc.  MarketScreener Sun, 09 Nov 2025 23:00:00 GMT
 galecto, inc. reports strategic shift and financial results  TipRanks Fri, 07 Nov 2025 04:30:14 GMT
 Cancer drug developer Galecto's Q3 net loss narrows to $3.1 mln  TradingView Thu, 06 Nov 2025 22:20:01 GMT
 Galecto, Inc. Reports Strategic Shift and Financial Results  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 Galecto Reports Third Quarter 2025 Operating and Financial Results  MarketScreener Thu, 06 Nov 2025 08:00:00 GMT
 Galecto to Highlight GB3226 Program at ASH 2025  The Manila Times Mon, 03 Nov 2025 14:25:10 GMT
 galecto trading resumes  MSN Fri, 31 Oct 2025 04:40:33 GMT

Galecto, Inc
(NASDAQ:GLTO) 

GLTO stock logo

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of sever...

Founded: 2011
Full Time Employees: 23
CEO: Hans Thalsgård Schambye  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends